Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).
BMJ open respiratory research·2026
Same author
Patient and staff acceptability of an artificial intelligence software to prioritize chest X-rays in an NHS setting: a qualitative evaluation.
BMC health services research·2026
Related Experiment Video
Updated: May 24, 2026
04:30
Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis
Published on: January 17, 2025
Systemic elastin degradation in chronic obstructive pulmonary disease.
John D Maclay1, David A McAllister, Roberto Rabinovich
1ELEGI Colt Laboratory, Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. johnmaclay@gmail.com
Thorax
|March 1, 2012
Summary
Patients with chronic obstructive pulmonary disease (COPD) show increased skin elastin degradation, linked to emphysema and vascular stiffness. This suggests a systemic issue affecting multiple organs in COPD patients.
Area of Science:
- Pulmonary Medicine
- Dermatology
- Cardiovascular Science
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with emphysema and vascular stiffness.
- A common mechanism involving elastin degradation may underlie these conditions.
Purpose of the Study:
- To determine if patients with COPD exhibit systemic elastin degradation in their skin.
- Investigate the relationship between skin elastin degradation and COPD severity.
Main Methods:
- Skin biopsies analyzed for elastin degradation via immunohistochemistry.
- Gene expression (MMP-2, -9, -12, TIMP-1) and protein levels of MMP-2 and -9 measured.
- Arterial stiffness and emphysema severity quantified using pulse wave velocity and CT scans.
Main Results:
- COPD patients had significantly higher skin elastin degradation in both sun-exposed and non-exposed areas compared to controls.
- Increased MMP-9 expression and concentration in COPD patients' skin correlated with elastin degradation.
- Cutaneous elastin degradation was associated with emphysema severity, FEV1, and arterial stiffness.
Conclusions:
- COPD patients exhibit elevated skin elastin degradation, correlating with emphysema and arterial stiffness.
- Increased proteolytic activity leading to systemic elastin degradation may be a unifying mechanism for COPD's pulmonary, vascular, and cutaneous manifestations.